Urinary mono-hydroxy polycyclic aromatic hydrocarbons (OH-PAHs) are commonly used in biomonitoring to assess exposure to polycyclic aromatic hydrocarbons (PAHs). Similar to other biologically non-persistent chemicals, OH-PAHs have relatively short biological half-lives (4.4-35 h). Little information is available on their variability in urinary concentrations over time in non-occupationally exposed subjects. This study was designed to (i) examine the variability of nine urinary OH-PAH metabolite concentrations over time and (ii) calculate sample size requirements for future epidemiological studies on the basis of spot urine, first-morning void, and 24-h void sampling. Individual urine samples (n ¼ 427) were collected during 1 week from 8 non-occupationally exposed adults. We recorded the time and volume of each urine excretion, dietary details, and driving activities of the participants. Within subjects, the coefficients of variation (CVs) for the wet-weight concentration of OH-PAHs in all samples ranged from 45% to 297%; creatinine adjustment reduced the CV to 19-288% (Po0.001; paired t-test). The simulated 24-h void concentrations were the least variable measure, with CVs ranging from 13% to 182% for the 9 OH-PAHs. Within-day variability contributed on average 84%, and between-day variability accounted for 16% of the total variance of 1-hydroxypyrene (1-PYR). Intraclass correlation coefficients of 1-PYR levels were 0.55 for spot urine samples, 0.60 for firstmorning voids, and 0.76 for 24-h voids, indicating a high degree of correlation between urine measurements collected from the same subject over time. Sample size calculations were performed to estimate the number of subjects required for detecting differences in the geometric mean at a statistical power of 80% for spot urine, first-morning, and 24-h void sampling. These data will aid in the design of future studies of PAHs and possibly other biologically non-persistent chemicals and in the interpretation of their analytical results.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a group of pollutants formed during incomplete combustion and are ubiquitously distributed in air, soil, water, food, and in many occupational settings (IARC, 1983) . Human exposure to PAHs can occur through inhalation of polluted air or cigarette smoke, ingestion of food containing PAHs, and dermal absorption from soil or other PAH-containing materials, such as coal tar. For the general population, ingestion and inhalation are the two dominant routes of exposure (ATSDR, 1995; Bostrom et al., 2002) . For certain occupations, such as coke oven workers, dermal absorption can become a major exposure route (ATSDR, 1995) . PAHs such as benzo(a)pyrene have been classified as probable human and animal carcinogens (ATSDR, 1995) . PAHs have also been associated with reproductive, developmental, hemato-, cardio-, neuro-, and immuno-toxicities (ATSDR, 1995) . Urinary PAH metabolites, specifically the mono-hydroxy PAH metabolites (OH-PAHs), have been used as biomarkers for assessing human exposure to PAHs, with 1-hydroxypyrene (1-PYR) as the most commonly used biomarker (Jacob and Seidel, 2002) . A number of studies have reported the levels of OH-PAHs in occupational groups, including coke oven workers and road pavers (Jongeneelen et al., 1990; Grimmer et al., 1993; Levin et al., 1995) , as well as in the general population from various parts of the world (Hansen et al., 2005; Mucha et al., 2006) . In the United States, OH-PAHs are included in the National Health and Nutrition Examination Survey (NHANES) conducted by the CDC (Centers for Disease Control and Prevention), an on-going survey that reports the concentrations of biomarkers in a statistically representative sample of the US population. In that survey, OH-PAHs are measured in B3000 samples every 2 years (Li et al., 2008) .
The half-life for urinary 1-PYR in humans has been reported to be 9.8 h (Brzeznicki et al., 1997 ) and 6-35 h (Jongeneelen et al., 1990) after inhalation exposure, 4.4 h (Buckley and Lioy, 1992) and 12 h after ingestion exposure, 11.5-15 h after dermal absorption , and 3.9-26.7 h (average: 10.4 h) after inhalation and dermal absorption (Boogaard and van Sittert, 1994) . Information on half-lives of the other OH-PAHs is scarce; however, as these are the same group of metabolites formed under similar biological pathways, we can reasonably deduce that other OH-PAHs measured in this study would have similar half-lives. Owing to the short half-lives of PAHs, the information provided by urinary biomonitoring is limited to recent exposure. Furthermore, the half-life information should be considered in study design, and appropriate samples must be collected within the window during which PAHs are excreted in the urine after exposure.
Theoretically, a 24-h void specimen represents the total and average daily metabolite excretion more reliably than does a spot urine sample. Thus, 24-h urine collection was recommended by the US EPA for evaluating exposure to pesticides and other toxic substances that are primarily eliminated in the urine (U.S. EPA, 1996) . However, this sampling method is burdensome on the study subjects, and non-compliance can lead to a compromised or a biased sampling. A common alternative is to collect the firstmorning urine, as has been done in many occupational and environmental exposure investigations, because the firstmorning urine is often correlated with the 24-h void (Kissel et al., 2005; Scher et al., 2007; Han et al., 2008) . In epidemiological studies such as NHANES involving thousands of participants, first-morning voids are often difficult to obtain; hence, spot urine samples have been used as a more practical solution. However, non-standardized sampling increases the variance, especially for short-lived compounds such as OH-PAHs, and changes in water consumption throughout the day increase the variance even further. Therefore, concentration adjustments, such as creatinine correction, have often been used to adjust for urine excretion rate and to minimize variability of the urinary biomarker concentrations caused by different hydration status of the participants .
The epidemiological study design should include a good understanding of the variability within a normal, nonexposed population or group of interest (IPCS, 1993) . Furthermore, because most potential health effects are likely associated with exposure over time, understanding the temporal variability of urinary biomarker levels from subjects with no occupational exposure is essential for both data interpretation and study design. At present, little is known about the variability of urinary OH-PAH levels. Siwinska et al. (1998) found that the concentration of 1-PYR in first-morning urine samples collected on 6 consecutive days from 30 children had a within-person coefficient of variation (CV) range of 14-109%, whereas the inter-person variation was 69-109%. Grimmer et al. (1993) reported that the intra-person variation in 24-h voids during 4 consecutive days from 4 coke workers had a range of 14-41% for 1-PYR and 16-94% for mono-hydroxy phenanthrene metabolites. Ovrebo et al. (1995) found that the intra-individual CVs of 1-PYR in post-shift urine samples were o0.50 for half of the workers during a 2.5-year study. Han et al. (2008) reported a significant (40-62%) intra-person difference between first-morning and 24-h voids in 100 adults. Although these studies provided some information on the variability of first-morning and 24-h void samples, they could not address the variability of spot urine samples excreted at any time of the day, nor did they address temporal variation of urinary OH-PAHs. Further, they could not provide a comparison between the three sampling approaches, that is, spot, first-morning, and 24-hour void.
The objectives of this study were to evaluate the variability of 9 commonly detectable OH-PAHs, metabolites of naphthalene, fluorene, phenanthrene, and pyrene, in adults with no occupational exposure of more than 7 days. Our design allowed us to determine the between-and withinsubject variability and the between-and within-day variability, as well as apportion the variance to subject and day effects for spot, first-morning, and 24-h void samples. In addition, we calculated the sample size requirements for the three sampling approaches. The findings of this investigation are applicable to the study design of future exposure assessments or epidemiological studies involving exposures to PAHs and potentially other non-persistent chemicals, which have short biological half-lives and are eliminated in urine (Needham and Sexton, 2000) .
Methods

Study Design
The 8 subjects in this study were healthy volunteers between 26 and 58 years of age with no known occupational PAH exposure. They were non-smokers who were not subjected to second-hand smoking. The participants (four men and four women) lived in the metropolitan Atlanta area and drove to and from work in the morning and afternoon during the weekdays (Monday-Friday), with a median driving time of 30 min (for one way) and a median distance of 21 km (for one way). The participants did not work during the weekend (Saturday and Sunday), when they engaged in only sporadic driving.
During the 1-week study period, participants collected all urine excretions in a graduated beaker, recorded the volume and time of each excretion, and transferred a portion (B50 ml) to a pre-labeled sterile urine cup, which was then stored in an ice cooler. The urine samples were retrieved from each participant daily (or after the weekend), brought back to the laboratory, and frozen at À70 1C until analysis. Participants also recorded detailed information on dietary intake, driving, and other outdoor activities.
Laboratory Methods
The method used to measure the urinary OH-PAH metabolites has been described previously (Li et al., 2006) . In brief, urine samples were spiked with 13 C-labeled internal standards and sodium acetate buffer containing b-glucuronidase enzyme, hydrolyzed overnight at 37 1C, and then extracted by n-pentane through semi-automated liquidliquid extraction. The extracts were evaporated, derivatized, and analyzed on a 6890 gas chromatograph (Agilent Technology, Palo Alto, CA, USA) coupled with a MAT 95XL high-resolution mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). All analyses were subjected to a series of quality control and quality assurance checks as described elsewhere (Li et al., 2006) . Urinary creatinine was measured on a Roche Hitachi 912 Chemistry Analyzer (Hitachi, Pleasanton, CA, USA) using the Creatinine Plus Assay, as described in Roche's Creatinine Plus Product Application no. 03631761003.
Statistical Analysis
All statistical analyses were carried out through SAS 9.1.3 (SAS Institute, Cary, NC, USA) and Statistica 7.1 (StatSoft, Tulsa, OK, USA). Concentrations below the limit of detection (LOD) were replaced with the LOD divided by the square root of 2 before data analysis. The urinary metabolite concentrations followed a log-normal distribution; therefore, all data were log-transformed before statistical analysis.
A total of 427 samples were collected from 8 subjects over 1 week. We defined the first-morning void sample as the first sample collected from each subject after 0500 hours each day. The simulated 24-h void concentration was calculated as the volume-weighted average of all urine specimens collected by an individual during a 24-h period starting at midnight. Subject 8 (S8) had a high dietary intake of PAHs on the fourth day of the study period, and concentrations of all OHPAHs for this subject increased up to 104-fold within 12 h. Hence, data from this subject for the 2 days affected by the high dietary intake were excluded from further variability and sample size calculations.
To assess the between-and within-subject as well as the between-and within-day variance, we calculated the contributions of each effect toward the total variance for four metabolites: 1-naphthol (1-NAP), 3-hydroxyfluorene (3-FLUO), 3-hydroxyphenanthrene (3-PHEN), and 1-PYR. We performed this calculation by using a random effects model fitted through the PROC NESTED, PROC MIXED, and PROC VARCOMP procedures in SAS. As all models produced similar results, we chose to present only the results from the PROC NESTED model. We calculated intraclass correlation coefficients (ICCs), defined as the ratio of between-subject variance to the total variance, as an indicator of reproducibility of repeated measurements over time (McGraw and Wong, 1996) . A high ICC value indicates high correlation and high reproducibility between repeated samples from the same subject. Using the findings from this study, we performed sample size calculations, including one to four repeated samples from each subject. Separate calculations were performed for spot sample, first-morning void, and 24-h void. The percentage differences in the geometric means (GMs) used for the sample size calculation between the two groups (e.g., controls vs cases) were 10%, 25%, 50%, and 100%. All of our analyses were carried out on log-transformed data; hence, we converted percentage differences in the GM to a difference (d) on the mean of logtransformed concentrations for the power calculation (Supplementary Information, Appendix 1). The number of subjects (m) required per group to achieve a desired type I error (a ¼ 0.05) and power (P ¼ 0.8) was calculated using the following formula (Diggle et al., 1994) :
where: D ¼ d/SD is the smallest meaningful difference between groups in SD units; n ¼ number of repeated samples per subject; Z y ¼ yth percentile of a standard Gaussian distribution; b ¼ type II error ¼ 1ÀP.
Results
We quantified 9 OH-PAH metabolites in 427 samples collected from 8 subjects during 1 week. The GM, median and quartile concentrations from all samples, first-morning voids, and simulated 24-h voids are shown in Table 1 . The detection rates were above 95% for all reported analytes, except for 2-hydroxyphenanthrene (2-PHEN, 82%) and 3-FLUO (87%). During the 7-day study period, each of the 8 subjects collected an average of 53 urine samples (27-74 samples per subject, Figure 1 ). Urinary OH-PAH concentrations within subjects varied from two to three orders of magnitude (Supplementary Information, Table S-1). For example, the concentration of 2-naphthol (2-NAP) in subject 7 (S7) ranged from 86 to 17,069 ng/l during the 7-day study period. Within subjects, the CVs of the 9 OH-PAHs among all samples, first-morning voids, and 24-h voids were 45-297%, 26-189%, and 13-182%, respectively. After creatinine adjustment, the CVs were 19-288%, 9-176%, and 9-154%, respectively (Supplementary Information, Table S -2). Levels of urinary PAH biomarkers in each subject varied throughout the day, as exemplified in Figure 2 . The 1-PYR concentration over time, stratified by subject, is provided in Figure 1 . One of the subjects (S8) ate barbecued chicken for lunch on Thursday; as a result, concentrations of the 9 metabolites increased by 22-104-fold after that exposure (Figures 1 and 3) . Twenty-four hours after the dietary exposure, the concentration of the urinary metabolites monitored returned to pre-exposure levels. Data for Thursday and Friday from S8 were excluded from further variability analysis and sample size calculations. The between-subject variance contributed 49-59% to the total variance of 1-NAP, 3-FLUO, 3-PHEN, and 1-PYR (creatinine-adjusted, unless specified otherwise), and the within-subject variance explained on average 41-60% for the 7 days of sampling (Figure 4a ). For the 8 subjects, the within-day variance for 1-NAP, 3-FLUO, 3-PHEN, and 1-PYR contributed to 60%, 71%, 90%, and 84% (average of 8 subjects) of the total variance, respectively (Figure 4b ). The contributions of the subjects, day, and hour effect to the total variance of all samples, first-morning voids, and 24-h voids are shown in Table 2 .
The number of subjects required per group to detect a difference of 10%, 25%, 50%, and 100% in urinary 1-PYR concentration is shown in Table 3 . Sample size calculations were performed to reflect the following three sampling methods: (i) spot sample collected anytime during the day, (ii) first-morning void, and (iii) 24-h void. Separate estimates of sample size are given for one through four repeated samples from each subject.
Discussion
Concentrations and Profiles
Overall, concentration levels found in this adult population with no occupational PAH exposure were lower than the reference levels established for the US general adult population (Table 1) . Wet-weight concentrations in firstmorning voids were significantly higher than in all samples and simulated 24-h voids. The differences diminished after creatinine adjustment, indicating that the higher wet-weight concentrations in the first-morning voids were caused by the more concentrated urine formed overnight and also that creatinine adjustment is an effective normalization method.
Within each subject, concentration levels of the urinary OH-PAH metabolites varied throughout the day (Figures 1  and 2 ). An apparent diurnal pattern (i.e., higher concentration in the early and late hours of the day and lower concentration during the middle of the day) of wet-weight concentrations was observed in one subject during weekdays, but not during weekends (Figure 2 ). Creatinine normalization effectively removed or reduced this daily pattern, suggesting that urine dilution related to variation in water consumption throughout the day was the likely explanation for the higher wet-weight concentrations at the beginning and the end of each day. In this study, we found that certain metabolites had distinct concentration profiles over time, compared with other metabolites from the same individual. For example, 1-NAP had an elevated peak in S8 starting on Tuesday afternoon, whereas all other analytes, including 1-PYR, stayed at background levels during the same time period (Figure 3 ). This subject exercised at a fitness center freshly sprayed with a cleaner or pesticide, which could be the most likely source for the elevated 1-NAP concentration shortly after the workout, as 1-NAP has been reported to be a metabolite of carbaryl pesticide (Maroni et al., 2000) . Similar large increases of only one or two metabolites occurred in other subjects (data not shown), but they could not be explained by the information collected. The unique concentration profile specific to only one or two OH-PAHs showed the individuality of each metabolite, the importance of a multi-analyte assay for exposure assessment, and the potential of using individual biomarkers as indicators of specific source-related exposure scenarios.
One subject (S8) consumed barbecued chicken during the study period. As a result, concentrations of all 9 metabolites increased 22-104-fold within hours of the exposure. This exposure overwhelmed other potential sources during the study period (c.f. Figure 3) . Therefore, data from the two days affected by the exposure were excluded from the variability analysis for this subject. A similar observation that dietary PAH intake can significantly affect the interindividual variability of the baseline excretion of urinary 1-PYR in non-smokers has been noted previously (Van Rooij et al., 1994) . Furthermore, we strongly recommend that in an exposure-assessment study investigating non-dietary sources, consumption of smoked, grilled, or barbecued food should be avoided or be used as an exclusion criteria to prevent data biasing.
Variability Analysis
We found that levels of the PAH biomarkers spanned three orders of magnitude during a course of 1 week (Supplementary Table S-1). Within each of the 7 subjects (not including S8), the CVs of wet-weight 1-PYR were 48-96%, 30-99% and 21-44% in all samples, first-morning voids, and 24-h voids, respectively. The within-subject variability in this study was comparable with results from a study on first-morning voids from 30 children (21-109%, 6 samples per person) (Siwinska et al., 1998) and with another study on 24-h voids from 4 workers (14-41%, 4 samples per person) (Grimmer et al., 1993) . Of all 9 OH-PAH concentrations, the within-subject CVs were 45-270% in all samples, 26-153% in first-morning voids, and 13-140% in 24-h voids (Supplementary Table S studied creatinine adjustment in individual urine samples collected over 24-h or longer periods from 50 subjects. They found that creatinine excretion parallels that of 1-PYR, creatinine normalization had a smoothing effect on 1-PYR excretion profiles, and was valid and necessary for biomonitoring of exposure to PAHs. Therefore, creatinine-corrected concentrations were used for all further variance and sample size calculations for these two sampling methods. Creatinine adjustment did not affect the variability of 24-h void concentrations, which is consistent with the premise that humans excrete creatinine at a relatively consistent rateFB2% of body creatine is converted to creatinine every 24 h . Therefore, creatinine adjustment is not necessary for 24-h voids, but is essential for spot samples and first-morning voids.
For individual subjects, the within-day variance exceeded the between-day variance, contributing 72-89% to total variance (Figure 4b ), which could be caused by changes in daily routine, diet, and metabolic pattern. This finding illustrates the need to control for known exposures when analyzing the association between a particular exposure and biomarker level. Moreover, it illustrates the difficulty in attributing small changes in biomarker level to a single exposure. In general, the between-subject variance outweighed the between-day variance for 3-FLUO, 3-PHEN, and 1-PYR, whereas for urinary 1-NAP concentrations, the day effect contributed equally or more toward the total variance than did the subject effect (Table 2) . For spot samples, 38-56% of the total variances among the 4 metabolites could not be explained by either the subject or the day factor; these variances could be attributed to the time-of-day effectFa finding that re-emphasizes the understanding of effect from time of the day during epidemiological study design.
ICC value, calculated as the ratio of between-subject variance to the total variance, had a range of 0.30-0.55 for spot samples, 0.33-0.65 for first-morning voids, and 0.44-0.77 for 24-h voids. The lower ICC values found in spot samples indicated higher within-subject variability and lower reproducibility from repeated urine collections from the same individual. On the other hand, the 24-h void was proven to be the most reproducible sampling technique, with markedly higher ICC values up to 0.77. As a comparison, the ICC values were 0.20-0.57 in first-morning voids during an 8-consecutive-day study of urinary metabolites of phthalates, another group of non-persistent chemicals with similar halflives (Fromme et al., 2007) . In another study of urinary phthalate metabolites in spot urine samples collected over a 3-month period, the ICCs ranged from 0.28 to 0.52 (Hauser et al., 2004) . The observed ICCs of urinary OH-PAH levels in our study were very similar to those reported on metabolites from other chemical classes with short half-lives, and there was a considerable degree of temporal reproducibility for these biomarkers over the study period of 1 week.
Sample Size Recommendation
In any cross-sectional or longitudinal epidemiological studies, investigators need to know in advance the approximate number of subjects required to achieve a desired statistical power. We found only one publication that reported sample size recommendations for urinary OH-PAH biomonitoring. Siwinska et al. (1998) calculated that the minimum number of subjects required for assessing exposure of a child population to environmental PAHs was 164, based on the variability of urinary 1-PYR concentrations in 6 consecutive first-morning voids from 30 children. However, the method used in that estimation was based on the assumption that the data were independent, an assumption that could be problematic because urinary biomarker concentrations are correlated. The ICCs for 1-PYR in our study were 0.55, 0.60, and 0.76, for spot samples, first-morning-voids, and 24-h voids, respectively, indicating considerable agreement between repeated measurements. Using the variability and correlation findings from our study, we calculated sample size requirements for urinary 1-PYR, with one to four repeated samples, simulating the three different sampling methods. See Table 3 for more information. As expected, the number of subjects required per group is the highest for spot samples, followed by first-morning voids and 24-h voids, because of the higher variability in the spot samples. Repeated sampling from the same subjects can reduce the sample size requirements, and the lower correlation and reproducibility in spot samples makes this approach benefit more from repeated sampling. For example, taking an additional sample per person reduces the sample size by 23%, 20%, and 13% for spot samples, first-morning, and 24-h voids, respectively. The sample size requirement can be Numbers in italic are intraclass correlation coefficients (ICCs), defined as the ratio of between-subject variance to total variance. Table 3 . Estimated number of samples required to detect a difference of 10%, 25%, 50%, and 100% in the 1-hydroxypyrene geometric mean concentration with a statistical power of 80% (Po0.05), for single and repeated sampling for spot, first-morning, and 24-h void sampling.
further reduced by collecting additional repeated samples from each person; however, the benefit lessens with each additional sample, especially if three or more samples are collected per person. As expected, the sample size requirements when using wet-weight concentrations are significantly higher than for creatinine-adjusted concentrations in spot urine samples and first-morning voids. The greater sample size requirement for wet-weight concentrations can be explained by higher variability of wet-weight concentrations in these two sampling methods. However, for 24-h voids, the sample size requirement is lower when using wet-weight concentrations, a finding that is consistent with the previous conclusion that creatinine adjustment is not required for 24-h voids.
To detect a difference of 10% in the GM with a statistical power of 80%, a total of 606 spot urine samples (creatinine adjusted) will be required per group to reach the desired statistical difference, while 296 24-h void samples (unadjusted) would be sufficient to reach the same statistical power. Hence, it is of utmost importance that these considerations be taken into account when one is planning an epidemiological study, as an investigator will need to balance the additional labor of collecting 24-h void samples with the costs of recruiting and analyzing more than twice as many samples to reach the same statistical power.
